ToxSci Advance Access originally published online on December 5, 2006
Toxicological Sciences 2007 97(1):205-213; doi:10.1093/toxsci/kfl180
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Troglitazone-Induced Hepatic Necrosis in an Animal Model of Silent Genetic Mitochondrial Abnormalities
,1
* Department of Pharmacology, Yong Loo Lin School of Medicine
Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore 117 597
1 To whom correspondence should be addressed at Molecular Toxicology Lab, Department of Pharmacology, National University of Singapore, MD2, 18 Medical Drive, Singapore 117 597. Fax: +65-6873-7690. E-mail: phcbua{at}nus.edu.sg.
Received September 6, 2006; accepted November 29, 2006
 |
Abstract |
|---|
Troglitazone, a first-generation thiazolidinedione antidiabetic drug, was withdrawn from the market due to an unacceptable risk of idiosyncratic hepatotoxicity. Troglitazone does not cause hepatotoxicity in normal healthy rodents, but it produces mitochondrial injury in vitro at high concentrations. The aim of this study was to explore whether genetic mitochondrial abnormalities might sensitize mice to hepatic adverse effects of troglitazone. We used heterozygous superoxide dismutase 2 (Sod2+/–) mice as a model of clinically silent mitochondrial stress. Troglitazone was daily administered for 4 weeks (0, 10 or 30 mg/kg/day, ip). We found that troglitazone caused overt liver injury in the high-dose group, manifested by increased serum alanine aminotransferase activity (> twofold) and midzonal areas of hepatic necrosis, in Sod2+/– but not in wild-type mice. No signs of hepatotoxicity were apparent at 2 weeks of treatment. Hepatic mitochondria isolated from troglitazone-treated mice exhibited decreased activities of aconitase (by 45%) and complex I (by 46%) and increased (by 58%) protein carbonyls, indicative of enhanced mitochondrial oxidant stress. This was paralleled by compensatory increases in mitochondrial glutathione levels. Finally, in hepatocytes isolated from untreated Sod2+/–, but not wild-type mice, troglitazone caused a concentration-dependent increase in superoxide anion levels as demonstrated with a selective mitochondria-targeting fluorescent probe. In conclusion, prolonged administration of troglitazone can superimpose oxidant stress, potentiate mitochondrial damage, and induce delayed hepatic necrosis in mice with genetically compromised mitochondrial function. These data are consistent with our hypothesis that inherited or acquired mitochondrial abnormalities may be one of the contributing determinants of susceptibility to troglitazone-induced idiosyncratic liver injury.
Key Words: drug-induced liver injury (DILI); idiosyncratic drug toxicity; oxidative stress; mitochondria; determinants of susceptibility; hepatotoxicity; superoxide dismutase.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S Verma and N Kaplowitz Diagnosis, management and prevention of drug-induced liver injury Gut, November 1, 2009; 58(11): 1555 - 1564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Deng, J. P. Luyendyk, P. E. Ganey, and R. A. Roth Inflammatory Stress and Idiosyncratic Hepatotoxicity: Hints from Animal Models Pharmacol. Rev., September 1, 2009; 61(3): 262 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fujimoto, K. Kumagai, K. Ito, S. Arakawa, Y. Ando, S.-i. Oda, T. Yamoto, and S. Manabe Sensitivity of Liver Injury in Heterozygous Sod2 Knockout Mice Treated with Troglitazone or Acetaminophen Toxicol Pathol, February 1, 2009; 37(2): 193 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Dykens, J. D. Jamieson, L. D. Marroquin, S. Nadanaciva, J. J. Xu, M. C. Dunn, A. R. Smith, and Y. Will In Vitro Assessment of Mitochondrial Dysfunction and Cytotoxicity of Nefazodone, Trazodone, and Buspirone Toxicol. Sci., June 1, 2008; 103(2): 335 - 345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Merrick The plasma proteome, adductome and idiosyncratic toxicity in toxicoproteomics research Brief Funct Genomic Proteomic, February 12, 2008; (2008) eln004v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. K. Lim, J. Liu, M. L. Go, and U. A. Boelsterli The Mitochondrial Superoxide/Thioredoxin-2/Ask1 Signaling Pathway is Critically Involved in Troglitazone-Induced Cell Injury to Human Hepatocytes Toxicol. Sci., February 1, 2008; 101(2): 341 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Marroquin, J. Hynes, J. A. Dykens, J. D. Jamieson, and Y. Will Circumventing the Crabtree Effect: Replacing Media Glucose with Galactose Increases Susceptibility of HepG2 Cells to Mitochondrial Toxicants Toxicol. Sci., June 1, 2007; 97(2): 539 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Jaeschke Troglitazone Hepatotoxicity: Are We Getting Closer to Understanding Idiosyncratic Liver Injury? Toxicol. Sci., May 1, 2007; 97(1): 1 - 3. [Full Text] [PDF]
|
|